Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wyeth To Set Up Asia’s Largest Milk Formula Factory In Suzhou

This article was originally published in PharmAsia News

Executive Summary

Wyeth has announced plans to build Asia's largest milk formula factory in Suzhou, China. It has received the National Development and Reform Commission's approval for the new plant occupying 12 hectare of land, targeted for completion by the end of 2010. With an initial output of 90 million pounds (about 40,000 tons) of high-quality baby milk powder formula, the plant is expected to have a maximum production capacity of up to 80,000 tons. Wyeth officials decline to reveal the investment amount but analysts estimate the total capital injection to be more than $250 million. Research firm IMS projects the milk formula market in China to reach $3 billion in 2010, with high-quality formula occupying half. (Click here for more - Chinese Language)

You may also be interested in...



Wyeth Builds Major New Facility In China

SHANGHAI - Wyeth will invest $280 million to build a state-of-the-art nutritional manufacturing facility in Jiangsu Province's Suzhou Industrial Park, the company announced March 10 during the foundation laying ceremony

At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use

At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.

Simplified Clinical Trial Transparency Rules To Go Live In The EU In June

A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules. 

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067877

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel